SCHEMBL18862260

SCHEMBL18862260

N#Cc1ccccc1-c1ccc(CN2CCCC2c2ccccn2)o1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ IL33 O95760 2/20 0.42
▸ CXCR4 P61073 4/20 0.41
▸ LMNA P02545 1/20 0.40
▸ SCD5 Q86SK9 2/20 0.39
▸ POLB P06746 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ HDAC1 Q13547 1/20 0.37
▸ USP30 Q70CQ3 1/20 0.36
▸ HRH3 Q9Y5N1 1/20 0.35
▸ PDE4B Q07343 1/20 0.35
▸ UTS2R Q9UKP6 1/20 0.34
▸ BRD4 O60885 1/20 0.33
▸ GNRHR P30968 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14837256 0.78 IL33 (0.39) IL33CXCR4LMNAPOLBKDM4E
SCHEMBL327871 0.68 CXCR4 (0.53) CXCR4LMNAPOLBKDM4ENPC1
SCHEMBL13509614 0.66 CXCR4 (0.54) CXCR4LMNAPOLBKDM4ENPC1
SCHEMBL13508572 0.65 CXCR4 (0.53) CXCR4LMNAPOLBKDM4ENPC1
SCHEMBL13090356 0.65 CXCR4 (0.50) CXCR4LMNAPOLBKDM4ENPC1
SCHEMBL9465382 0.64 CXCR4 (0.54) CXCR4LMNAPOLBKDM4ENPC1
SCHEMBL13186652 0.64 CXCR4 (0.52) CXCR4LMNAPOLBKDM4ENPC1
SCHEMBL13995495 0.63 CXCR4 (0.51) CXCR4LMNAPOLBKDM4ENPC1
SCHEMBL21516720 0.63 CXCR4 (0.42) CXCR4LMNAPOLBKDM4ENPC1
SCHEMBL21516110 0.62 CXCR4 (0.46) CXCR4LMNAPOLBKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017083242-A1 INHIBITORS OF SUPPRESSION OF TUMORIGENCITY 2 (ST2) AND METHODS USING THE SAME THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2017-05-18 — — WO disclosed
Send feedback